Dec. 29, 2022 -- A pharmaceuticals company is voluntarily recalling blood pressure medication because an impurity was detected in recent testing, the Food and Drug Administration said this week.

No illnesses have been reported from the Quinapril Tablets produced by Lupin Pharmaceuticals Inc., the FDA said.

“The tablets were contaminated by substances known as nitrosamines, which the FDA reports are commonly found in food and water,” The Hill reported. “These impurities are found in meats, dairy products and vegetables, and can increase a person’s risk of developing cancer when faced with prolonged exposure, according to the FDA.”

The Quinapril Tablet USP is an angiotensin-converting enzyme inhibitor

prescribed for hypertension to lower blood pressure. It was distributed across the country to wholesalers, drug chains, mail order pharmacies in supermarkets in 2021 and 2022.

The FDA advises people taking the tablets to continue taking them and to contact their health care professional for advice on an alternate treatment. Sellers should stop distributing the tablets right away.

The FDA says anyone with questions should call (877) 538-8445 from Monday to Friday, 9 a.m. to 5 p.m. EST. 

Show Sources

The Hill: “FDA recalls blood pressure medication over cancer risks”

FDA: “Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets Due to Potential Presence of N-Nitroso-Quinapril Impurity”


© 2022 WebMD, LLC. All rights reserved. View privacy policy and trust info